The Servelec Group is a UK-based technology group, with significant intellectual property, providing software, hardware and services predominantly to the UK healthcare, oil & gas, nuclear, power, utilities and broadcast sectors.


The Servelec Group’s business was founded in 1977 and, since October 2000, has been wholly-owned by CSE Global, a company whose shares are traded on the main board of the Singapore Stock Exchange. Servelec has a strong technology and engineering heritage and today employs a highly skilled and knowledgeable workforce of approximately 500 full-time staff operating predominantly from offices around the UK. The majority of these staff are based at the Group’s purpose built offices in Sheffield, one of which functions as the Group’s headquarters.

The origins of the Group’s business were in the design and manufacture of control systems for the Sheffield steel industry. Since that time, Servelec has grown both organically and by acquisition and now operates two divisions: Servelec Healthcare and Servelec Automation.

Servelec Healthcare specialises in the design, development and implementation of Electronic Patient Record ("EPR") software within secondary care settings and is a market leader in the Mental Health and Community Health sectors in England.


Servelec Automation provides complex, mission-critical control systems to large, blue-chip, companies mainly in the UK. Servelec Automation provides the whole lifecycle of services from consultancy, through to design, implementation, delivery, installation and on-going customer support and maintenance.


http://www.servelec-group.com/index.html

Shares - Servelec marks tech IPO shift


It is possible that the IPO of Servelec (SERV) will act as a catalyst for a significant shift in the type and scale of technology floats in 2014. More than 20 tech IPOs have joined the London stock market this year, with several more floating in 2012, yet the majority have been fast-growing yet small in scale, many fitting neatly into the microcap ecosystem.

Sheffield-headquartered Servelec is a different beast. It has a trading track record stretching back to the late 1970s. In its last published full-year results to December 2012, Servelec produced revenues of £40.8 million and earnings before interest, tax, depreciation and amortisation (EBITDA) of £11.5 million. By contrast, WANdisco (WAND:AIM), an undoubted star of the tech IPO space recently, produced £3.7 million of revenues in 2012. Direct comparisons would be unfair given the pair’s very different histories, products and growth profiles, but it illustrates the shortage of sizeable IPOs to date.

Servelec operates healthcare and energy/utilities automation divisions, and has been spun-out of Singaporean private equity house CSE Global. Offering the shares at 179p implies a £122 million market value, making it the UK’s biggest tech float for three years, and the software sector’s biggest since 2000. Judging by the share price response in early trading – the stock has jumped to 215p, a 20% premium to an already top-of-the-range valuations – the ravenous appetite of investors for many of this year’s tech IPOs shows little sign of ebbing. Cornerstone institutions include Schroders Investment Management and Henderson Global Investors, notes the FT, with 19.7% and 16% stakes respectively.

Yet with multiple moving parts and seemingly little synergy between its two divisions, analysts at Megabuyte point out that it is on the healthcare side ‘where we see the most reliable comparable valuations.’ In this space independents such as Advanced Computer Software (ASW) and EMIS (EMIS) give pointers, both trading on rough 11-times trailing EBITDA multiples, compared to Servelec’s IPO-priced 10.6-times.

Only time will tell if the market is right to chase Servelec beyond this valuation to the 12.8-times implied by early trading shifts. But wherever the market decides Servelec’s valuation should stand medium-term, investors should welcome the tech IPO shake-up implied by its successful float. There’s clearly professional and private investor cash sloshing around looking for exciting tech stories to invest in, so let’s keep our fingers crossed that we’ll see many more tech businesses of scale find their way onto the LSE’s main or Aim markets.

Holding(s) in Company -

Nortrust Nominees Ltd - 5%


http://www.moneyam.com/action/news/showArticle?id=4717681

Holding(s) in Company

Quantum Partners LP 5.72%

http://www.moneyam.com/action/news/showArticle?id=4720323

Seem to be on the move. Up 7.80% today

The naked trader - I've also bought an interesting new one: Servelec (SERV) at 212.

It's a tech group that provides services to healthcare, energy and broadcast services. It's a main listing too rather than AIM which makes it a bit less scary and volatile than AIM new ones.

That'll mean also it'll go into the small cap index which should attract fund managers. I would think there is a pretty good chance of contract win news items which will eventually lift the price which is quiet at the moment.

It's a market leader which last year made an ajusted profit of just under £12m so the market cap doesn't look too stretched giving potential good upside.

lol.

Holding(s) in Company


Old Mutual Plc - crossed 8%

http://www.moneyam.com/action/news/showArticle?id=4725625

Servelec Group PLC (SERV:LSE) set a new high during today's trading session when it reached 235.00. Since the IPO on Dec 02, 2013, the share price is up 9.30%.

Nice and steady climb since its IPO

Off topic ,are you putting up a thread for RM2 monday DC ?

Will do Jimmy. Just going in with the left foot ie half my original stake and watch. A piece in IC today, looks positive but hard to value the company. Financial info limited.

yes we are all anxious to read the rampety on that one!

My god.

I'M getting bloody sick of you mate.

Has the MD been out with your wife halifax :)

as usual more abuse we all know IPO's are being ramped atm.

Surely we are all analysing stocks here hoping we pick the right one's.

Post Year End Trading Statement

RNS


RNS Number : 6533X

Servelec Group plc

15 January 2014




15 January 2014



Servelec Group plc



Post Year End Trading Up-date



Following the successful listing on the main market of the London Stock Exchange on Monday 2 December, Servelec Group plc ("Servelec"), today announces a trading up-date for the year ended 31 December 2013.



Since the listing, Servelec has continued the good progress it made through 2013 and the full-year results will be in line with the Board's expectations.



Sales activity in Healthcare is increasing and Servelec has been awarded the first two Trust wins as part of the on-going Camden (London and the South) re-fresh programme. With regards to Servelec Automation, across both Controls and Technologies, the anticipated shift from the design stage to the pricing stage for our products and services with a number of our customers continues to progress in line with our expectations.



Following the acquisition of Semaphore in October 2013, the integration programme is progressing well and we are delighted to have recruited Andrew Sullivan from Ultra Electronics as Managing Director of Servelec Technologies to further assist this process.



Alan Stubbs, Chief Executive, commented: "Following our successful listing, we are pleased that our strong performance has continued to deliver a full-year performance in line with the Board's expectations. The outlook for the structural and regulatory growth drivers across our markets remains encouraging and we are looking forward to capitalising on these exciting opportunities as a listed company."



Preliminary results for the year ended 31 December 2013 will be announced on 12 March 2014.

Servelec Healthcare Contract Wins

RNS


RNS Number : 1599A

Servelec Group plc

17 February 2014




17 February 2014

Servelec Group plc



Servelec Healthcare contract wins



Servelec Group plc ("Servelec") today announces that its Healthcare division has started 2014 with strong continued progress in contract wins.



Servelec Healthcare has been awarded another preferred supplier status under the London Framework for Mental Health and Community. This means that it has now won three contracts out of three in the Application Lot 1, as well as two wins in Hosting Lot 2.



In addition, in January, Servelec Healthcare took a Portsmouth Hospitals NHS Trust live with its Oceano Emergency Department Solution. The delivery was the quickest installation to date by Servelec Healthcare with the project commencing late 2013 and was achieved in the most challenging winter period that A&E departments have seen for some time. The company's Oceano customers are growing and this new live installation brings the total deployments of this innovative product to three new sites.



Servelec's activity and presence in the Community Health sector has also strengthened with a Community win in the North of England for a Spine-connected Community hospital deployment which went live at the beginning of the year.



Alan Stubbs, Chief Executive Officer, commented:



"We are excited about the start that Servelec Healthcare has made to the year, three out of three in the London Refresh, together with two successful go-lives. It is an illustration that our healthcare division has the right product portfolio, market position, route to market and delivery capability to capitalise on the growth opportunities ahead."



Preliminary results for the year ended 31 December 2013 will be announced on 12 March 2014.

Big move up again today in a weaker market, small cap inclusion next few weeks?!